Evidence for dysfunction of the endogenous oxytocin system in craniopharyngioma is limited and mixed, with differential findings depending on the paradigms used to measure oxytocin concentrations (e.g., single baseline measurements vs. response to intervention) and the stratification of analyses by hypothalamic damage. Here, OXT is linked to craniopharyngioma.